Engendering Reproductive Health Within Oncologic Survivorship Trial, ECOG-ACRIN E1Q11
Ashlesha Patel, Ju‐Whei Lee, Howard A. Zaren, Erika K. Radeke et autres
us, gb (code pays fourni par la source)
0 citations
JCO Oncology Practice
Jessica Jones Croley
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
21Publications signalées
27Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Lung Cancer Treatments and MutationsMyasthenia Gravis and ThymomaGastrointestinal Tumor Research and TreatmentCancer Risks and FactorsFibroblast Growth Factor Research
Les publications récentes
Supplementary Figure S4 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Table S4 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Figure S6 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Table S5 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Table S3 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Figure S5 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Table S1 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Data from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Figure S1 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Figure S2 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
Supplementary Table S2 from Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
Niamh Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.